lobbying_activities: 1438900

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1438900	a96ecda9-13f9-4e5d-9dd9-c2dd55a37909	Q3	CAPITOL HILL CONSULTING GROUP	72053	PROFESSIONAL COMPOUNDING CENTERS OF AMERICA	2013	third_quarter	PHA	Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)	HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2013-10-08T13:52:15.407000-04:00